Compare PDYN & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDYN | QTRX |
|---|---|---|
| Founded | 1983 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.5M | 306.0M |
| IPO Year | N/A | 2017 |
| Metric | PDYN | QTRX |
|---|---|---|
| Price | $7.45 | $5.90 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 3 |
| Target Price | $8.00 | ★ $11.33 |
| AVG Volume (30 Days) | ★ 2.0M | 560.9K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $250.22 | $28.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $4.14 | $4.15 |
| 52 Week High | $12.79 | $8.77 |
| Indicator | PDYN | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 44.24 |
| Support Level | $6.87 | $5.55 |
| Resistance Level | $7.89 | $6.38 |
| Average True Range (ATR) | 0.52 | 0.44 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 86.27 | 38.10 |
Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.